3.090USD-2.83%Mkt Cap: 13.49M USDP/E: —Last update: 2026-06-01
Cyclerion Therapeutics, Inc., a biopharmaceutical company, engages in the development of treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periph…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap13.49M USD
Enterprise Value10.82M USD
Revenue (TTM)1.99M USD
Gross Profit1.03M USD
Net Income (TTM)-3.53M USD
Revenue/Share0.5550 USD
Last Price3.090 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.40
PEG—
EV/EBITDA—
EV/Revenue5.43
P/S6.84
P/B1.97
EPS (TTM)-1.31
EPS (Forward)-1.31
52W Range
1.02728% of range8.480
52W High8.480 USD
52W Low1.027 USD
Profitability
Gross Margin51.88%
Oper. Margin-337.43%
EBITDA Margin0.00%
Profit Margin-170.11%
ROE-38.83%
ROA-35.33%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.31M USD
CapEx (TTM)—
FCF Margin-129.91%
FCF Yield-19.19%
Net Debt-2.82M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio1.80
Quick Ratio1.65
Book Value/Sh1.601 USD
Cash/Share0.6520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateMay 16, 2023
Analyst Consensus
Rating—
Target (Mean)8.000 USD
Target Range8.000 USD – 8.000 USD
# Analysts1
Ownership
Shares Out.4.33M
Float3.58M
Insiders24.26%
Institutions4.17%
Short Interest
Short Ratio0.2d
Short % Float0.74%
Short % Out.0.62%
Shares Short26.66K
Short (prev mo.)267.35K
Technical
SMA 502.942 (+5.0%)
SMA 2002.100 (+47.1%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)80.83K
Avg Vol (10d)44.38K
Technical Indicators
RSI (14)54.3
MACD0.0587
MACD Signal0.0731
MACD Hist.-0.0144
BB Upper3.290 USD
BB Middle3.151 USD
BB Lower3.012 USD
BB Width8.83%
ATR (14)0.2231 USD
Vol Ratio (20d)0.51x